Patents by Inventor Robert Rieben

Robert Rieben has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment and prevention of remote ischemia-reperfusion injury
    Patent number: 10973891
    Abstract: The present invention relates to a contact activation system inhibitor, preferably a C1INH, for use in the treatment and/or prevention of remote ischemia-reperfusion injury (IRI), comprising administering the contact activation system inhibitory to an individual.
    Type: Grant
    Filed: March 20, 2019
    Date of Patent: April 13, 2021
    Assignees: CSL Behring GmbH, Universitaet Bern
    Inventors: Rolf Spirig, Sylvia Miescher, Marc Nolte, Claudia Duehrkop-Sisewitsch, Robert Rieben
  • TREATMENT AND PREVENTION OF REMOTE ISCHEMIA-REPERFUSION INJURY
    Publication number: 20190269766
    Abstract: The present invention relates to a contact activation system inhibitor, preferably a C1INH, for use in the treatment and/or prevention of remote ischemia-reperfusion injury (IRI), comprising administering the contact activation system inhibitory to an individual.
    Type: Application
    Filed: March 20, 2019
    Publication date: September 5, 2019
    Inventors: Rolf SPIRIG, Sylvia MIESCHER, Marc NOLTE, Claudia DUEHRKOP-SISEWITSCH, Robert RIEBEN
  • Treatment and prevention of remote ischemia-reperfusion injury
    Patent number: 10286047
    Abstract: The present invention relates to a contact activation system inhibitor, preferably a C1INH, for use in the treatment and/or prevention of remote ischemia-reperfusion injury (IRI), comprising administering the contact activation system inhibitory to an individual.
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: May 14, 2019
    Assignees: CSL Behring GmbH, Universität Bern
    Inventors: Rolf Spirig, Sylvia Miescher, Marc Nolte, Claudia Duehrkop-Sisewitsch, Robert Rieben
  • TREATMENT AND PREVENTION OF REMOTE ISCHEMIA-REPERFUSION INJURY
    Publication number: 20160008442
    Abstract: The present invention relates to a contact activation system inhibitor, preferably a C1INH, for use in the treatment and/or prevention of remote ischemia-reperfusion injury (IRI), comprising administering the contact activation system inhibitor to an individual.
    Type: Application
    Filed: March 7, 2014
    Publication date: January 14, 2016
    Inventors: Rolf SPIRIG, Sylvia MIESCHER, Marc NOLTE, Claudia DUEHRKOP-SISEWITSCH, Robert RIEBEN
  • Non-glycosylated polyacrylamide conjugates and their use for cytoprotection
    Publication number: 20050214248
    Abstract: The present invention relates to new non-glycosylated polyacrylamide conjugates, a method for protecting endothelial cells from complement-mediated cellular damage and the use of said non-glycosylated polyacrylamide conjugates as a medicament.
    Type: Application
    Filed: August 12, 2003
    Publication date: September 29, 2005
    Inventors: Robert Rieben, Paul Mohacsi, Nicolai Bovin, Elena Korchagina